Insider Trading Alert - MD, G And HLX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 10, 2014, 92 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,000.16 to $941,600,000.00.

Highlighted Stocks Traded by Insiders:

Mednax (MD) - FREE Research Report

Andreano Dominic J, who is SVP, General Counsel and Secy at Mednax, sold 2,252 shares at $58.48 on June 10, 2014. Following this transaction, the SVP, General Counsel and Secy owned 20,391 shares meaning that the stake was reduced by 9.95% with the 2,252-share transaction.

The shares most recently traded at $58.09, down $0.39, or 0.67% since the insider transaction. Historical insider transactions for Mednax go as follows:

  • 4-Week # shares sold: 60,365
  • 12-Week # shares sold: 60,365
  • 24-Week # shares sold: 72,565

The average volume for Mednax has been 577,100 shares per day over the past 30 days. Mednax has a market cap of $5.8 billion and is part of the health care sector and health services industry. Shares are up 10.15% year-to-date as of the close of trading on Tuesday.

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, and other pediatric subspecialties care physician services in the United States and Puerto Rico. The company has a P/E ratio of 20.5. Currently, there are 8 analysts who rate Mednax a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MD - FREE

TheStreet Quant Ratings rates Mednax as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Mednax Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Genpact (G) - FREE Research Report

Guaglianone Victor, who is SVP & General Counsel at Genpact, sold 11,346 shares at $16.96 on June 10, 2014. Following this transaction, the SVP & General Counsel owned 28,068 shares meaning that the stake was reduced by 28.79% with the 11,346-share transaction.

The shares most recently traded at $17.10, up $0.14, or 0.8% since the insider transaction. Historical insider transactions for Genpact go as follows:

  • 4-Week # shares sold: 31,824
  • 12-Week # shares sold: 52,245
  • 24-Week # shares sold: 52,245

The average volume for Genpact has been 1.0 million shares per day over the past 30 days. Genpact has a market cap of $3.7 billion and is part of the services sector and diversified services industry. Shares are down 7.62% year-to-date as of the close of trading on Tuesday.

Genpact Limited provides business process management and information technology services worldwide. The company has a P/E ratio of 17.4. Currently, there are 6 analysts who rate Genpact a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on G - FREE

TheStreet Quant Ratings rates Genpact as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Genpact Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Helix Energy Solutions Group (HLX) - FREE Research Report

Tripodo Anthony, who is Executive Vice President & CFO at Helix Energy Solutions Group, sold 8,178 shares at $24.60 on June 10, 2014. Following this transaction, the Executive Vice President & CFO owned 191,721 shares meaning that the stake was reduced by 4.09% with the 8,178-share transaction.

The shares most recently traded at $25.03, up $0.43, or 1.72% since the insider transaction. Historical insider transactions for Helix Energy Solutions Group go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 3,500
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 8,500
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 33,500

The average volume for Helix Energy Solutions Group has been 840,200 shares per day over the past 30 days. Helix Energy Solutions Group has a market cap of $2.7 billion and is part of the basic materials sector and energy industry. Shares are up 8.89% year-to-date as of the close of trading on Tuesday.

Helix Energy Solutions Group, Inc., an offshore energy company, together with its subsidiaries, provides specialty services to the offshore energy industry, primarily in the Gulf of Mexico, North Sea, the Asia Pacific, and West Africa regions. The company has a P/E ratio of 16.6. Currently, there are 3 analysts who rate Helix Energy Solutions Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HLX - FREE

TheStreet Quant Ratings rates Helix Energy Solutions Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Helix Energy Solutions Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

Nasdaq Edges Higher as Tech Stocks Rebound, Dow Slips

Nasdaq Edges Higher as Tech Stocks Rebound, Dow Slips

These Stocks Are Making U-Turns

These Stocks Are Making U-Turns

Why the Boardroom Doesn't Need Ivy League Degrees

Why the Boardroom Doesn't Need Ivy League Degrees

Mednax: Solid Growth at a Good Price

Mednax: Solid Growth at a Good Price